An optimized protocol for the retroviral transduction of mouse CD4 T cells
Summary: Transduction of primary T cells has become prominent with the introduction of chimeric antigen receptor T-cell therapy. Although there are many protocols for the transduction of human T cells, it remains a challenge to transduce murine T cells. We present an optimized protocol for the retro...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-09-01
|
Series: | STAR Protocols |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666166721004263 |
id |
doaj-c64dd8db782a4cf282175d61248356e4 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ekaterina Eremenko Zoe V. Taylor Bishnu Khand Shir Zaccai Angel Porgador Alon Monsonego |
spellingShingle |
Ekaterina Eremenko Zoe V. Taylor Bishnu Khand Shir Zaccai Angel Porgador Alon Monsonego An optimized protocol for the retroviral transduction of mouse CD4 T cells STAR Protocols Cell culture Cell-based Assays Cell separation/fractionation Immunology Molecular Biology |
author_facet |
Ekaterina Eremenko Zoe V. Taylor Bishnu Khand Shir Zaccai Angel Porgador Alon Monsonego |
author_sort |
Ekaterina Eremenko |
title |
An optimized protocol for the retroviral transduction of mouse CD4 T cells |
title_short |
An optimized protocol for the retroviral transduction of mouse CD4 T cells |
title_full |
An optimized protocol for the retroviral transduction of mouse CD4 T cells |
title_fullStr |
An optimized protocol for the retroviral transduction of mouse CD4 T cells |
title_full_unstemmed |
An optimized protocol for the retroviral transduction of mouse CD4 T cells |
title_sort |
optimized protocol for the retroviral transduction of mouse cd4 t cells |
publisher |
Elsevier |
series |
STAR Protocols |
issn |
2666-1667 |
publishDate |
2021-09-01 |
description |
Summary: Transduction of primary T cells has become prominent with the introduction of chimeric antigen receptor T-cell therapy. Although there are many protocols for the transduction of human T cells, it remains a challenge to transduce murine T cells. We present an optimized protocol for the retroviral transduction of murine CD4 T cells, which overcomes major challenges including large-scale production and long-term culturing of transduced cells. The optimized protocol combines high transduction efficiency with a low rate of cell death.For complete details on the use and execution of this protocol, please refer to Eremenko et al., 2019. |
topic |
Cell culture Cell-based Assays Cell separation/fractionation Immunology Molecular Biology |
url |
http://www.sciencedirect.com/science/article/pii/S2666166721004263 |
work_keys_str_mv |
AT ekaterinaeremenko anoptimizedprotocolfortheretroviraltransductionofmousecd4tcells AT zoevtaylor anoptimizedprotocolfortheretroviraltransductionofmousecd4tcells AT bishnukhand anoptimizedprotocolfortheretroviraltransductionofmousecd4tcells AT shirzaccai anoptimizedprotocolfortheretroviraltransductionofmousecd4tcells AT angelporgador anoptimizedprotocolfortheretroviraltransductionofmousecd4tcells AT alonmonsonego anoptimizedprotocolfortheretroviraltransductionofmousecd4tcells AT ekaterinaeremenko optimizedprotocolfortheretroviraltransductionofmousecd4tcells AT zoevtaylor optimizedprotocolfortheretroviraltransductionofmousecd4tcells AT bishnukhand optimizedprotocolfortheretroviraltransductionofmousecd4tcells AT shirzaccai optimizedprotocolfortheretroviraltransductionofmousecd4tcells AT angelporgador optimizedprotocolfortheretroviraltransductionofmousecd4tcells AT alonmonsonego optimizedprotocolfortheretroviraltransductionofmousecd4tcells |
_version_ |
1717376159208964096 |
spelling |
doaj-c64dd8db782a4cf282175d61248356e42021-09-19T05:00:45ZengElsevierSTAR Protocols2666-16672021-09-0123100719An optimized protocol for the retroviral transduction of mouse CD4 T cellsEkaterina Eremenko0Zoe V. Taylor1Bishnu Khand2Shir Zaccai3Angel Porgador4Alon Monsonego5The Shraga Segal Department of Microbiology, Immunology, and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel; The Department of Physiology and Cell Biology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel; The Department of Life Sciences, Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel; The National Institute of Biotechnology in the Negev, Zlotowski Neuroscience Center, and Regenerative Medicine and Stem Cell Research Center, Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel; Corresponding authorThe Shraga Segal Department of Microbiology, Immunology, and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel; The Department of Physiology and Cell Biology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel; The National Institute of Biotechnology in the Negev, Zlotowski Neuroscience Center, and Regenerative Medicine and Stem Cell Research Center, Ben-Gurion University of the Negev, Beer Sheva 8410501, IsraelThe Shraga Segal Department of Microbiology, Immunology, and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel; The Department of Physiology and Cell Biology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel; The National Institute of Biotechnology in the Negev, Zlotowski Neuroscience Center, and Regenerative Medicine and Stem Cell Research Center, Ben-Gurion University of the Negev, Beer Sheva 8410501, IsraelThe Shraga Segal Department of Microbiology, Immunology, and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel; The Department of Physiology and Cell Biology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel; The Department of Life Sciences, Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel; The National Institute of Biotechnology in the Negev, Zlotowski Neuroscience Center, and Regenerative Medicine and Stem Cell Research Center, Ben-Gurion University of the Negev, Beer Sheva 8410501, IsraelThe Shraga Segal Department of Microbiology, Immunology, and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel; The Department of Physiology and Cell Biology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel; The National Institute of Biotechnology in the Negev, Zlotowski Neuroscience Center, and Regenerative Medicine and Stem Cell Research Center, Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel; Corresponding authorThe Shraga Segal Department of Microbiology, Immunology, and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel; The Department of Physiology and Cell Biology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel; The National Institute of Biotechnology in the Negev, Zlotowski Neuroscience Center, and Regenerative Medicine and Stem Cell Research Center, Ben-Gurion University of the Negev, Beer Sheva 8410501, Israel; Corresponding authorSummary: Transduction of primary T cells has become prominent with the introduction of chimeric antigen receptor T-cell therapy. Although there are many protocols for the transduction of human T cells, it remains a challenge to transduce murine T cells. We present an optimized protocol for the retroviral transduction of murine CD4 T cells, which overcomes major challenges including large-scale production and long-term culturing of transduced cells. The optimized protocol combines high transduction efficiency with a low rate of cell death.For complete details on the use and execution of this protocol, please refer to Eremenko et al., 2019.http://www.sciencedirect.com/science/article/pii/S2666166721004263Cell cultureCell-based AssaysCell separation/fractionationImmunologyMolecular Biology |